Marc Semigran - Net Worth and Insider Trading
Marc Semigran Net Worth
The estimated net worth of Marc Semigran is at least $193,018 dollars as of 2024-12-28. Marc Semigran is the Chief Development Officer of Edgewise Therapeutics Inc and owns about 6,716 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $193,018. Marc Semigran is also the Chief Medical Officer of MyoKardia Inc and owns about 0 shares of MyoKardia Inc (MYOK) stock worth over $0. Details can be seen in Marc Semigran's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marc Semigran has not made any transactions after 2024-12-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Marc Semigran
Marc Semigran Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marc Semigran owns 6 companies in total, including MyoKardia Inc (MYOK) , Renovacor Inc (RCOR) , and Social Capital Suvretta Holdings Corp III (DNAC) among others .
Click here to see the complete history of Marc Semigran’s form 4 insider trades.
Insider Ownership Summary of Marc Semigran
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MYOK | MyoKardia Inc | 2019-02-08 | Chief Medical Officer |
RCOR | Renovacor Inc | 2021-09-02 | Chief Medical Officer |
DNAC | Social Capital Suvretta Holdings Corp III | 2021-06-29 | director |
2021-06-29 | director | ||
2022-12-19 | Chief Development Officer | ||
2021-09-02 | Chief Medical Officer |
Marc Semigran Latest Holdings Summary
Marc Semigran currently owns a total of 2 stocks. Among these stocks, Marc Semigran owns 6,716 shares of Edgewise Therapeutics Inc (EWTX) as of December 24, 2024, with a value of $193,018 and a weighting of 100%. Marc Semigran also owns 0 shares of MyoKardia Inc (MYOK) as of September 5, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Marc Semigran
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EWTX | Edgewise Therapeutics Inc | 2024-12-24 | 6,716 | 28.74 | 193,018 |
MYOK | MyoKardia Inc | 2018-09-05 | 0 | 224.91 | 0 |
Holding Weightings of Marc Semigran
Marc Semigran Form 4 Trading Tracker
According to the SEC Form 4 filings, Marc Semigran has made a total of 1 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Edgewise Therapeutics Inc is the sale of 29,709 shares on December 24, 2024, which brought Marc Semigran around $882,060.
According to the SEC Form 4 filings, Marc Semigran has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the sale of 45,000 shares on September 5, 2018, which brought Marc Semigran around $3 Million.
Insider Trading History of Marc Semigran
- 1
Marc Semigran Trading Performance
Marc Semigran Ownership Network
Marc Semigran Owned Company Details
What does MyoKardia Inc do?
Who are the key executives at MyoKardia Inc?
Marc Semigran is the Chief Medical Officer of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .
MyoKardia Inc (MYOK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
MyoKardia Inc Insider Transactions
Marc Semigran Mailing Address
Above is the net worth, insider trading, and ownership report for Marc Semigran. You might contact Marc Semigran via mailing address: C/o Myokardia, Inc., 333 Allerton Ave, South San Francisco Ca 94080.